These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18655832)

  • 21. A structurally based approach to determine HLA compatibility at the humoral immune level.
    Duquesnoy RJ
    Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
    Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():800946. PubMed ID: 35154076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
    Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
    Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 16th IHIW: a website for antibody-defined HLA epitope Registry.
    Duquesnoy RJ; Marrari M; da M Sousa LC; de M Barroso JR; de S U Aita KM; da Silva AS; do Monte SJ
    Int J Immunogenet; 2013 Feb; 40(1):54-9. PubMed ID: 23136897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
    Duquesnoy RJ
    Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should epitope-based HLA compatibility be used in the kidney allocation system?
    Duquesnoy RJ
    Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.
    Adeyi OA; Girnita AL; Howe J; Marrari M; Awadalla Y; Askar M; Martell J; Zeevi A; Shapiro R; Nalesnik M; Randhawa P; Demetris AJ; Duquesnoy RJ
    Transpl Immunol; 2005 Mar; 14(1):53-62. PubMed ID: 15814283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
    Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
    Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of the HLA molecular structure to transplantation.
    Park MS; Terasaki PI; Barbetti A; Han H; Cecka JM
    Clin Transpl; 1988; ():301-28. PubMed ID: 2484900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching.
    Tambur AR; Buckingham M; McDonald L; Luo X
    Clin Transpl; 2006; ():399-404. PubMed ID: 18365396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Resse M; Paolillo R; Minucci BP; Moccia G; Napoli C
    Tissue Antigens; 2015 Nov; 86(5):368-72. PubMed ID: 26373475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New aspects of HLA compatibility in organ transplantation].
    Snanoudj R; Legendre C
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S125-30. PubMed ID: 26968475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA matching by amino acid/positions in double and triple combinations.
    Idica A; Sasaki N; Terasaki P
    Clin Transpl; 2006; ():123-38. PubMed ID: 18365374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns.
    Duquesnoy RJ; Mostecki J; Hariharan J; Balazs I
    Hum Immunol; 2008 Dec; 69(12):826-32. PubMed ID: 18957310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study.
    Daniëls L; Naesens M; Bosmans JL; Abramowicz D; Nagler E; Van Laecke S; Peeters P; Kuypers D; Emonds MP
    Transpl Immunol; 2018 Oct; 50():55-59. PubMed ID: 29908316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.